AAAAAA

   
Results: 1-16 |
Results: 16
p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast
Authors: Done, SJ Eskandarian, S Bull, S Redston, M Andrulis, IL
Citation: Sj. Done et al., p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast, J NAT CANC, 93(9), 2001, pp. 700-704
p53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers
Authors: Done, SJ Arneson, NCR Ozcelik, H Redston, M Andrulis, IL
Citation: Sj. Done et al., p53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers, BREAST CANC, 65(2), 2001, pp. 111-118
Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Authors: Gokgoz, N Wunder, JS Mousses, S Eskandarian, S Bell, RS Andrulis, IL
Citation: N. Gokgoz et al., Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma, CANCER, 92(8), 2001, pp. 2181-2189
p53 Mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance
Authors: Laframboise, S Chapman, W McLaughlin, J Andrulis, IL
Citation: S. Laframboise et al., p53 Mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance, CANCER J, 6(5), 2000, pp. 302-308
Factors affecting distant disease-free survival for primary invasive breast cancer: Use of a log-normal survival model
Authors: McCready, DR Chapman, JAW Hanna, WM Kahn, HJ Murray, D Fish, EB Trudeau, ME Andrulis, IL Lickley, HLA
Citation: Dr. Mccready et al., Factors affecting distant disease-free survival for primary invasive breast cancer: Use of a log-normal survival model, ANN SURG O, 7(6), 2000, pp. 416-426
MDR1 gene expression and outcome in osteosarcoma: A prospective, multicenter study
Authors: Wunder, JS Bull, SB Aneliunas, V Lee, PD Davis, AM Beauchamp, CP Conrad, EU Grimer, RJ Healey, JH Rock, MJ Bell, RS Andrulis, IL
Citation: Js. Wunder et al., MDR1 gene expression and outcome in osteosarcoma: A prospective, multicenter study, J CL ONCOL, 18(14), 2000, pp. 2685-2694
Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2
Authors: Phillips, KA Warner, E Meschino, WS Hunter, J Abdolell, M Glendon, G Andrulis, IL Goodwin, PJ
Citation: Ka. Phillips et al., Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2, CLIN GENET, 57(5), 2000, pp. 376-383
BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
Authors: Yazici, H Bitisik, O Akisik, E Cabioglu, N Saip, P Muslumanoglu, M Glendon, G Bengisu, E Ozbilen, S Dincer, M Turkmen, S Andrulis, IL Dalay, N Ozcelik, H
Citation: H. Yazici et al., BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients, BR J CANC, 83(6), 2000, pp. 737-742
Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene
Authors: Taylor, MD Gokgoz, N Andrulis, IL Mainprize, TG Drake, JM Rutka, JT
Citation: Md. Taylor et al., Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene, AM J HU GEN, 66(4), 2000, pp. 1403-1406
Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations
Authors: Phillips, KA Nichol, K Ozcelik, H Knight, J Done, SJ Goodwin, PJ Andrulis, IL
Citation: Ka. Phillips et al., Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations, J NAT CANC, 91(5), 1999, pp. 469-473
Mutation in the coding region of the BRCA1 gene leads to aberrant splicingof the transcript
Authors: Ozcelik, H Nedelcu, R Chan, VWY Shi, XH Murphy, J Rosen, B Andrulis, IL
Citation: H. Ozcelik et al., Mutation in the coding region of the BRCA1 gene leads to aberrant splicingof the transcript, HUM MUTAT, 14(6), 1999, pp. 540-541
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovariancancer
Authors: Khoo, US Ozcelik, H Cheung, ANY Chow, LWC Ngan, HYS Done, SJ Liang, ACT Chan, VWY Au, GKH Ng, WF Poon, CSP Leung, YF Loong, F Ip, P Chan, GSW Andrulis, IL Lu, J Ho, FCS
Citation: Us. Khoo et al., Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovariancancer, ONCOGENE, 18(32), 1999, pp. 4643-4646
Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas
Authors: Wunder, JS Eppert, K Burrow, SR Gogkoz, N Bell, RS Andrulis, IL
Citation: Js. Wunder et al., Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas, ONCOGENE, 18(3), 1999, pp. 783-788
Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours
Authors: Hopyan, S Gokgoz, N Bell, RS Andrulis, IL Alman, BA Wunder, JS
Citation: S. Hopyan et al., Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours, J ORTHOP R, 17(5), 1999, pp. 633-638
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma
Authors: Ginsberg, JP de Alava, E Ladanyi, M Wexler, LH Kovar, H Paulussen, M Zoubek, A Dockhorn-Dworniczak, B Juergens, H Wunder, JS Andrulis, IL Malik, R Sorensen, PHB Womer, RB Barr, FG
Citation: Jp. Ginsberg et al., EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma, J CL ONCOL, 17(6), 1999, pp. 1809-1814
Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?
Authors: Phillips, KA Andrulis, IL Goodwin, PJ
Citation: Ka. Phillips et al., Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?, J CL ONCOL, 17(11), 1999, pp. 3653-3663
Risultati: 1-16 |